On analyzing the mRNA expression levels of LPAR2 in pan-cancer and normal tissues using Oncomine, we found that LPAR2 expression was higher in bladder, brain and central nervous system (CNS), breast, colorectal, kidney, and lung cancers and lymphoma than in normal control tissues (Fig. 2A). This evidence concerns the gene LPAR2 and lymphoma.